RCS - Intnl. Biotechnology - Latest Factsheet and Blog

International Biotechnology Trust

02/08/2024 14:34

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240802:nRSB0430Za&default-theme=true

RNS Number : 0430Z  Intl. Biotechnology Trust PLC  02 August 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

IBT's factsheet for the month ended 30 June 2024 is now available directly via
its web page. Please click here
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
, then 'latest factsheet'.

 

In recent IBT blog posts, we've highlighted the improving outlook for the
biotechnology sector, noting the gradual improvement in the quality of
companies within the industry. Here, we delve into the accelerating innovation
and increased availability of finance in the biotechnology sector and examine
how these factors are shaping the outlook for investors.

 

In recent IBT blog posts, we have alluded to the improving outlook for the
biotechnology sector, and how the quality of the companies in the sector is
gradually improving. Here we take a look at the accelerating innovation and
availability of finance in the biotechnology sector, and how they are
influencing the outlook for investors.

 

The blog can be read here:

 

https://schro.link/ibt-blog-july-24 (https://schro.link/ibt-blog-july-24)

 

To sign up for IBT updates by email, please click here
(https://www.schroders.com/en-gb/uk/individual/never-miss-an-update/) .

 

 

ENDS

 

 

Enquiries:

 

 Schroder Investment Management Limited

 Kirsty Preston (PR)                                                     020 7658 6000

 Kerry Higgins (Company Secretary)                                       020 7658 6000

 Kaso Legg Communications (Financial PR)                                 IBT@kl-communications.com (mailto:IBT@kl-communications.com)

 Charles Gorman

 Henry Taylor

 Effie Aye Maung Hider

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAXLLFBZVLXBBL